130 related articles for article (PubMed ID: 2267995)
1. Chemical warfare casualties and yperite-induced xerodermoid.
Piérard GE; Dowlati A; Dowlati Y; Piérard-Franchimont C; Hermanns-Lê T; Letot B
Am J Dermatopathol; 1990 Dec; 12(6):565-70. PubMed ID: 2267995
[TBL] [Abstract][Full Text] [Related]
2. Late cutaneous manifestations 14 to 20 years after wartime exposure to sulfur mustard gas: a long-term investigation.
Emadi SN; Mortazavi M; Mortazavi H
Arch Dermatol; 2008 Aug; 144(8):1059-61. PubMed ID: 18711087
[No Abstract] [Full Text] [Related]
3. Chemical warfare agents: their past and continuing threat and evolving therapies. Part I of II.
Smith KJ; Skelton H
Skinmed; 2003; 2(4):215-21. PubMed ID: 14673274
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic effects of sulfur mustard on the skin: a comprehensive review.
Ghanei M; Poursaleh Z; Harandi AA; Emadi SE; Emadi SN
Cutan Ocul Toxicol; 2010 Dec; 29(4):269-77. PubMed ID: 20868209
[TBL] [Abstract][Full Text] [Related]
5. Medical defense against blistering chemical warfare agents.
Smith WJ; Dunn MA
Arch Dermatol; 1991 Aug; 127(8):1207-13. PubMed ID: 1863081
[TBL] [Abstract][Full Text] [Related]
6. Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16-20 years after exposure.
Hefazi M; Maleki M; Mahmoudi M; Tabatabaee A; Balali-Mood M
Int J Dermatol; 2006 Sep; 45(9):1025-31. PubMed ID: 16961503
[TBL] [Abstract][Full Text] [Related]
7. Urinary and cutaneous complications of sulphur mustard poisoning preceding pulmonary and ocular involvement: an unusual sequence of symptoms.
Emadi SN; Moeineddin F; Sorush MR
Clin Exp Dermatol; 2009 Jul; 34(5):e7-10. PubMed ID: 19040511
[TBL] [Abstract][Full Text] [Related]
8. [Cutaneous and systemic toxicology of vesicants used in warfare].
Pita R; Vidal-Asensi S
Actas Dermosifiliogr; 2010; 101(1):7-18. PubMed ID: 20109388
[TBL] [Abstract][Full Text] [Related]
9. Long-term skin damage due to chemical weapon exposure.
Firooz A; Sadr B; Davoudi SM; Nassiri-Kashani M; Panahi Y; Dowlati Y
Cutan Ocul Toxicol; 2011 Mar; 30(1):64-8. PubMed ID: 21047269
[TBL] [Abstract][Full Text] [Related]
10. Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy.
Smith KJ; Hurst CG; Moeller RB; Skelton HG; Sidell FR
J Am Acad Dermatol; 1995 May; 32(5 Pt 1):765-76. PubMed ID: 7722023
[TBL] [Abstract][Full Text] [Related]
11. Acute intensive care unit management of mustard gas victims: the Turkish experience
Kilic E; Ortatatli M; Sezigen S; Eyison RK; Kenar L
Cutan Ocul Toxicol; 2018 Dec; 37(4):332-337. PubMed ID: 29648477
[TBL] [Abstract][Full Text] [Related]
12. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent.
Khateri S; Ghanei M; Keshavarz S; Soroush M; Haines D
J Occup Environ Med; 2003 Nov; 45(11):1136-43. PubMed ID: 14610394
[TBL] [Abstract][Full Text] [Related]
13. Management of injuries due to chemical weapons.
Murray VS; Volans GN
BMJ; 1991 Jan; 302(6769):129-30. PubMed ID: 1822079
[No Abstract] [Full Text] [Related]
14. CO2 laser debridement of sulphur mustard (bis-2-chloroethyl sulphide) induced cutaneous lesions accelerates production of a normal epidermis with elimination of cytological atypia.
Smith KJ; Skelton HG; Martin JL; Hurst CG; Hackley BE
Br J Dermatol; 1997 Oct; 137(4):590-4. PubMed ID: 9390337
[TBL] [Abstract][Full Text] [Related]
15. Experience with mustard gas casualties.
Newman-Taylor AJ; Morris AJ
Lancet; 1991 Jan; 337(8735):242. PubMed ID: 1670873
[No Abstract] [Full Text] [Related]
16. Chemical Warfare's Most Notorious Agent Against the Skin: Mustard Gas-Then and Now.
Maranda EL; Ayache A; Taneja R; Cortizo J; Nouri K
JAMA Dermatol; 2016 Aug; 152(8):933. PubMed ID: 27532357
[No Abstract] [Full Text] [Related]
17. Cutaneous and ocular late complications of sulfur mustard in Iranian veterans.
Shohrati M; Peyman M; Peyman A; Davoudi M; Ghanei M
Cutan Ocul Toxicol; 2007; 26(2):73-81. PubMed ID: 17612976
[TBL] [Abstract][Full Text] [Related]
18. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas.
Momeni AZ; Enshaeih S; Meghdadi M; Amindjavaheri M
Arch Dermatol; 1992 Jun; 128(6):775-80. PubMed ID: 1599263
[TBL] [Abstract][Full Text] [Related]
19. Baicalin as a potentially promising drug for the management of sulfur mustard induced cutaneous complications: a review of molecular mechanisms.
Sahebkar A
Cutan Ocul Toxicol; 2012 Sep; 31(3):226-34. PubMed ID: 22107027
[TBL] [Abstract][Full Text] [Related]
20. Verification of exposure to sulfur mustard in two casualties of the Iran-Iraq conflict.
Benschop HP; van der Schans GP; Noort D; Fidder A; Mars-Groenendijk RH; de Jong LP
J Anal Toxicol; 1997; 21(4):249-51. PubMed ID: 9248939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
